ABSI
Price
$8.15Alerts
Change
-$0.03 (-0.37%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
1.75B
124 days until earnings call
Intraday BUY SELL Signals
CADL
Price
$5.13Alerts
Change
-$0.19 (-3.57%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
669.54M
133 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABSI vs CADL

ABSI vs CADL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABSI vs. CADL commentary
Nov 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and CADL is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ABSI with price predictions
Nov 18, 2026

ABSI's Stochastic Oscillator remains in oversold zone for 4 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +9.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where ABSI advanced for three days, in 241 of 268 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

ABSI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 142 of 175 cases where ABSI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ABSI as a result. In 74 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.

The Moving Average Convergence Divergence Histogram (MACD) for ABSI turned negative on November 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 40 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.

ABSI moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ABSI crossed bearishly below the 50-day moving average on November 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 19 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABSI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. ABSI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.091) is normal, around the industry mean (3.592). P/E Ratio (-12.873) is within average values for comparable stocks, (-1.190). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.305) among similar stocks. P/S Ratio (769.231) is also within normal values, averaging (442.120).

The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABSI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for CADL with price predictions
Nov 18, 2026

CADL sees MACD Histogram crosses below signal line

CADL saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 13, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 41 instances where the indicator turned negative. In 39 of the 41 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CADL as a result. In 88 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CADL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for CADL entered a downward trend on November 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +18.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where CADL advanced for three days, in 213 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

CADL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. CADL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.308) is normal, around the industry mean (3.592). P/E Ratio (-5.952) is within average values for comparable stocks, (-1.190). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.305) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (442.120).

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CADL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
ABSICADL
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 2 days ago
86%
COMPARISON
Comparison
Nov 19, 2026
Stock price -- (ABSI: $8.18 vs. CADL: $5.32)
Brand notoriety: ABSI and CADL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 142% vs. CADL: 114%
Market capitalization -- ABSI: $1.75B vs. CADL: $669.54M
ABSI [@Biotechnology] is valued at $1.75B. CADL’s [@Biotechnology] market capitalization is $669.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green while CADL’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • CADL’s FA Score: 0 green, 5 red.
According to our system of comparison, CADL is a better buy in the long-term than ABSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 4 TA indicator(s) are bullish while CADL’s TA Score has 4 bullish TA indicator(s).

  • ABSI’s TA Score: 4 bullish, 5 bearish.
  • CADL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CADL is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а -19.17% price change this week, while CADL (@Biotechnology) price change was -42.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.39%. For the same industry, the average monthly price growth was -12.15%, and the average quarterly price growth was -24.55%.

Reported Earning Dates

ABSI is expected to report earnings on Mar 23, 2027.

CADL is expected to report earnings on Apr 01, 2027.

Industries' Descriptions

@Biotechnology (-5.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with CRSP. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
+7.92%
CRSP - ABSI
61%
Loosely correlated
+0.10%
RXRX - ABSI
61%
Loosely correlated
+3.86%
BEAM - ABSI
57%
Loosely correlated
+1.74%
ABCL - ABSI
57%
Loosely correlated
-0.09%
SANA - ABSI
53%
Loosely correlated
-1.60%
More

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with VIR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
-1.48%
VIR - CADL
53%
Loosely correlated
-1.08%
NTLA - CADL
51%
Loosely correlated
-0.10%
EDIT - CADL
47%
Loosely correlated
-3.01%
ELDN - CADL
47%
Loosely correlated
+2.53%
ABSI - CADL
46%
Loosely correlated
+7.92%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LGL6.590.09
+1.38%
LGL Group (The)
CMCO19.66-0.19
-0.96%
Columbus McKinnon Corp
NMM83.26-2.45
-2.86%
Navios Maritime Partners LP
CPOP2.56-0.09
-3.40%
Pop Culture Group Co Ltd
GKOS233.08-10.17
-4.18%
Glaukos Corp